Use of a Peptide-based Formula in an Adult Population

Abbott

Status

Completed

Conditions

Malabsorption

Treatments

Other: Nutritional Study Product

Study type

Interventional

Funder types

Industry

Identifiers

NCT02750787

DA12

Details and patient eligibility

About

The study is designed to observe the use of a peptide-based oral nutrition supplement in adults with chronic malabsorption or maldigestion who require supplemental nutrition as assessed by a clinician.

Enrollment

37 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Subject is ≥ 18 years of age.
Subject has chronic malabsorption or maldigestion.
Subject requires supplemental nutrition as assessed by a clinician.
Subject agrees to consume 2 servings of the study product a day for at least 16 consecutive days during Treatment period.

Exclusion criteria

Subject is currently taking or has taken antibiotics within 2 weeks prior to enrollment in the study.
Subject has current active malignant disease or was treated within the last 6 months for cancer.
Subject has a history of diabetes mellitus.
Subject is pregnant as demonstrated by a urine pregnancy test.
Subject has severe auto immune disease and is on immuno-modulating therapy.
Subject has a history of allergy to any of the ingredients in the study product.
Subject has active HIV.
Subject has a known aversion to flavor of product being tested.
Subject has known dementia, brain metastases, eating disorders, history of significant neurological or psychiatric disorder, or any other psychological condition that may interfere with study product consumption.
Subject has an obstruction of the gastrointestinal tract precluding ingestion or absorption of the study product.
Subject is taking part in another non-Sponsor approved clinical trial.